Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102849322 | 10284932 | 2 | F | 20160815 | 20140708 | 20160818 | EXP | US-GLAXOSMITHKLINE-A1079679A | GLAXOSMITHKLINE | 59.00 | YR | M | Y | 0.00000 | 20160818 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102849322 | 10284932 | 1 | PS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNKNOWN DOSING | Y | 21077 | INHALATION POWDER | |||||||||
| 102849322 | 10284932 | 2 | SS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Y | 21077 | INHALATION POWDER | ||||||||||
| 102849322 | 10284932 | 3 | SS | FLOVENT | FLUTICASONE PROPIONATE | 1 | Unknown | UNKNOWN DOSING | Y | 0 | |||||||||
| 102849322 | 10284932 | 4 | SS | FLOVENT | FLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | UNK, BID | Y | 0 | BID | ||||||||
| 102849322 | 10284932 | 5 | SS | FLOVENT | FLUTICASONE PROPIONATE | 1 | Y | 0 | |||||||||||
| 102849322 | 10284932 | 6 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 PUFF(S), SINGLE | Y | 21077 | 1 | DF | INHALATION POWDER | ||||||
| 102849322 | 10284932 | 7 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Y | 21077 | INHALATION POWDER | ||||||||||
| 102849322 | 10284932 | 8 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Y | 21077 | INHALATION POWDER | ||||||||||
| 102849322 | 10284932 | 9 | C | PREDNISONE. | PREDNISONE | 1 | 10 MG, UNK | U | 0 | 10 | MG | ||||||||
| 102849322 | 10284932 | 10 | C | COMBIVENT | ALBUTEROL SULFATEIPRATROPIUM BROMIDE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102849322 | 10284932 | 1 | Chronic obstructive pulmonary disease |
| 102849322 | 10284932 | 2 | Emphysema |
| 102849322 | 10284932 | 3 | Emphysema |
| 102849322 | 10284932 | 4 | Bronchiectasis |
| 102849322 | 10284932 | 5 | Chronic obstructive pulmonary disease |
| 102849322 | 10284932 | 6 | Chronic obstructive pulmonary disease |
| 102849322 | 10284932 | 7 | Bronchiectasis |
| 102849322 | 10284932 | 8 | Emphysema |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102849322 | 10284932 | OT |
| 102849322 | 10284932 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102849322 | 10284932 | Cardiac failure congestive | |
| 102849322 | 10284932 | Chronic obstructive pulmonary disease | |
| 102849322 | 10284932 | Cough | |
| 102849322 | 10284932 | Device use error | |
| 102849322 | 10284932 | Feeling hot | |
| 102849322 | 10284932 | Hospitalisation | |
| 102849322 | 10284932 | Implantable defibrillator insertion | |
| 102849322 | 10284932 | Malaise | |
| 102849322 | 10284932 | Myocardial infarction | |
| 102849322 | 10284932 | Nasopharyngitis | |
| 102849322 | 10284932 | Rhinorrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102849322 | 10284932 | 4 | 2006 | 20160814 | 0 | |
| 102849322 | 10284932 | 6 | 2012 | 2012 | 0 |